Advances in inflammatory bowel diseases.
The annual clinical and research conference of the Crohn's and Colitis Foundation of America, Advances in Inflammatory Bowel Diseases, provided a comprehensive overview of the year's newest developments regarding inflammatory bowel diseases (IBD). The program was again successful. Attracting a wide range of participants including leaders in the field from around the world, the program offered a unique opportunity to review and debate the most important clinical studies, current controversies in the management of IBD, and the most recent perspectives on current research in the investigation of IBD.
Levy
L Campbell
LC
Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA. l.campbell.levy@hitchcock.org
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000472:pathogenicity; D003092:Colitis / Q000188:drug therapy* / Q000382:microbiology; D003424:Crohn Disease / Q000188:drug therapy*; D004761:Enterocolitis, Pseudomembranous; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors